Kinfo
Jupiter Neurosciences Inc. logo

Jupiter Neurosciences Inc.

JUNSNASDAQHealthcare·US · USD
$1.76
-0.10 (-5.38%)
Prices as of November 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap2.32M USD
Enterprise value1.58M USD
Trailing P/E-0.10
Forward P/E29.33
PEG ratio0.00
Price / sales35.87
Price / book-2.82
Profitability
Gross margin86.88%
Operating margin-15166.68%
Profit margin80.59%
Return on assets-159.56%
Return on equity-1888.70%
Income (TTM)
Revenue64.69K USD
Gross profit-1.82M USD
EBITDA0.00 USD
Net income-9.20M USD
Diluted EPS-$18.94
Rev. growth (YoY)29.99%
Balance sheet
Total cash1.52M USD
Total debt1.75M USD
Debt / equity-4.78
Current ratio0.66
Book value / share-$0.55
Cash flow (TTM)
Operating cash flow-7.25M USD
Levered free cash flow-3.26M USD
Shares & price
Shares outstanding642.99K
Float564.08K
Held by institutions3.89%
Beta0.00
50-day MA$2.70
200-day MA$17.57
52-week high$11.20
52-week low$0.07
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-052.883.30+14.58%2026-03-162.012.62+30.35%2025-12-12-0.68-2.83−316.18%2025-11-14-6.00-5.25+12.50%2025-10-151.341.37+2.24%
About Jupiter Neurosciences Inc.

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation, central nervous system disorders, and selected rare diseases. Its work centers on JOTROL, an enhanced oral resveratrol formulation designed for pharmaceutical use across conditions such as Parkinson’s disease, Alzheimer’s disease, and other neurological disorders. The company also operates a premium nutritional supplements segment through the Nugevia brand, which includes consumer products positioned around longevity, cognitive support, and wellness. Jupiter Neurosciences Inc. combines drug development with consumer health offerings, giving it a presence in both the biopharmaceutical and nutritional supplement markets. Headquartered in Jupiter, Florida, the company is organized around research, formulation technology, and commercial product development in the health sciences sector.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Christer Rosen
Employees
5
Headquarters
Jupiter, FL, United States

Frequently asked questions about Jupiter Neurosciences Inc.